Literature DB >> 2831073

Platelets as a model for neurones?

M Da Prada1, A M Cesura, J M Launay, J G Richards.   

Abstract

The multiple biochemical and pharmacological similarities existing between blood platelets and 5-hydroxytryptamine (5-HT)-containing neurones of the CNS point to the platelets as a reliable model for the biochemical characterization of 5-HT releasers and uptake blockers which interfere with the storage and the active carrier mechanism of 5-HT in the neurones, respectively. In addition, the affinity displayed by dopamine and by dopaminergic neurotoxin MPP+ for the platelet 5-HT transport and storage indicates also some similarities between platelets and the dopaminergic system of the CNS. Since human platelets contain almost exclusively monoamine oxidase type B (MAO-B), they can be used as a source for the purification and characterization of this human enzyme. Human platelets thus offer an excellent peripheral model to indirectly assess the degree and duration of MAO-B inhibition occurring in the CNS. To date, knowledge of the many biochemical mechanisms underlying platelet physiology is still fragmentary. In fact, the functional role of binding sites located on the platelet cytoplasmic membrane, i.e. their coupling to a specific transmembrane signalling mechanism, is still in need of a precise biochemical and physiological characterization.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2831073     DOI: 10.1007/BF01952193

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  91 in total

1.  Release of serotonin from blood platelets by reserpine in vitro.

Authors:  A CARLSSON; P A SHORE; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1957-07       Impact factor: 4.030

Review 2.  Regulated secretory pathways of neurons and their relation to the regulated secretory pathway of endocrine cells.

Authors:  P de Camilli; F Navone
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

3.  Shape change and uptake of 5-hydroxytryptamine in human blood platelets: action of neuropsychotropic drugs.

Authors:  A Laubscher; A Pletscher
Journal:  Life Sci       Date:  1979-05-14       Impact factor: 5.037

4.  Demonstration of specific "high affinity" binding sites for [3H] imipramine on human platelets.

Authors:  S M Paul; M Rehavi; P Skolnick; F K Goodwin
Journal:  Life Sci       Date:  1980-03-24       Impact factor: 5.037

5.  Solubilization of human platelet vasopressin receptors.

Authors:  M Thibonnier
Journal:  Life Sci       Date:  1987-02-02       Impact factor: 5.037

6.  Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits.

Authors:  F Gudat; A Laubscher; U Otten; A Pletscher
Journal:  Br J Pharmacol       Date:  1981-11       Impact factor: 8.739

7.  Conversion of the neurotoxic precursor 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine into its pyridinium metabolite by human platelet monoamine oxidase type B.

Authors:  M Da Prada; A M Cesura; R Kettler; G Zürcher; W E Haefely
Journal:  Neurosci Lett       Date:  1985-06-24       Impact factor: 3.046

8.  Dopamine uptake in platelets: two different low-affinity, saturable mechanisms.

Authors:  O Lingjaerde; O Kildemo
Journal:  Agents Actions       Date:  1981-07

9.  Rapid intracellular release of calcium in human platelets by stimulation of 5-HT2-receptors.

Authors:  P Erne; A Pletscher
Journal:  Br J Pharmacol       Date:  1985-02       Impact factor: 8.739

10.  Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1-receptors.

Authors:  M Vanderwel; D S Lum; R J Haslam
Journal:  FEBS Lett       Date:  1983-12-12       Impact factor: 4.124

View more
  30 in total

1.  Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism.

Authors:  C Albano; A Cupello; P Mainardi; S Scarrone; E Favale
Journal:  Neurochem Res       Date:  2006-05-13       Impact factor: 3.996

2.  Autoradiographic analysis of vasoactive neuropeptide uptake by rabbit megakaryocytes and platelets.

Authors:  T Daimon
Journal:  J Anat       Date:  1991-06       Impact factor: 2.610

3.  Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics.

Authors:  Martin A Javors; Chamindi Seneviratne; John D Roache; Nassima Ait-Daoud; Susan E Bergeson; M Consuelo Walss-Bass; Fatema Z Akhtar; Bankole A Johnson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-11-04       Impact factor: 5.067

4.  Can serotonin transporter genotype predict serotonergic function, chronicity, and severity of drinking?

Authors:  Bankole A Johnson; Martin A Javors; John D Roache; Chamindi Seneviratne; Susan E Bergeson; Nassima Ait-Daoud; Michael A Dawes; Jennie Z Ma
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-19       Impact factor: 5.067

Review 5.  Platelets: A possible glance into brain biological processes in schizophrenia.

Authors:  Eyal Asor; Dorit Ben-Shachar
Journal:  World J Psychiatry       Date:  2012-12-22

6.  Is the platelet serotonin transporter different in venous vs. arterial blood?

Authors:  Emiliano Villa; Claudio Albano; Andrea Cappelli; Emilio Favale; Emilia Fugassa; Ezio Gerdoni; Simona Scarrone; Aroldo Cupello
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

7.  Binding of paroxetine to the serotonin transporter in membranes from different cells, subcellular fractions and species.

Authors:  A Cupello; C Albano; E Gatta; S Scarrone; E Villa; G Zona
Journal:  Neurochem Res       Date:  2008-06-18       Impact factor: 3.996

8.  Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line.

Authors:  O Kellermann; S Loric; L Maroteaux; J M Launay
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

9.  Autoradiographic analysis of the uptake of [3H]dopamine, [3H]angiotensin II and [3H]gamma aminobutyric acid by the chicken thrombocyte.

Authors:  T Daimon; K Kawai; K Uchida
Journal:  J Anat       Date:  1993-04       Impact factor: 2.610

Review 10.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.